Form CORRESP - Correspondence:
SEC Accession No. 0001628280-20-014541
Filing Date
2020-10-16
Accepted
2020-10-16 17:15:32
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 13385
2 GRAPHIC cumberlandlogo1.jpg GRAPHIC 12332
  Complete submission text file 0001628280-20-014541.txt   26002
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: CORRESP
SIC: 2834 Pharmaceutical Preparations